Connect with us

Uncategorized

Staff Shortages and Surgical Backlogs Causing Vision Loss in Canada

Staff Shortages and Surgical Backlogs Causing Vision Loss in Canada
Canada NewsWire
OTTAWA, ON, Oct. 13, 2022

The Canadian Council of the Blind and Fighting Blindness Canada’s Report Card on Vision Health in Canada shows that progress in vision car…

Published

on

Staff Shortages and Surgical Backlogs Causing Vision Loss in Canada

Canada NewsWire

The Canadian Council of the Blind and Fighting Blindness Canada's Report Card on Vision Health in Canada shows that progress in vision care is slow as COVID-19 pandemic continued in 2021.

OTTAWA, ON, Oct. 13, 2022 /CNW/ - World Sight Day – "The Impact of the COVID-19 Pandemic on Vision Health in Canada 2021" report card found that vision care in Canada has not returned to pre-pandemic levels due to significant staff shortages, surgical backlogs and people not keeping their doctor appointments or having their regular eye examinations.

Despite substantial commitments from governments of over $2 billion across Canada to provide capacity to clear the backlog of people needing treatment, wait times and the delivery of eye care have not returned to pre-pandemic levels, underlying the urgent need for a national eye care strategy.

Canadians cannot access specialized care to prevent blindness, despite the fact that 3 out of 4 people can stop vision loss with early diagnosis and access to treatments. Two-thirds of Canadians have not had an eye exam in the past year, and it is estimated that there were 108,000 fewer eye surgeries performed in Canada in 2021 compared to 2019. There were 1.8 million fewer optometrist visits in 2021 compared to 2019.

Report card highlights:

Progress in vision care is happening, but not quickly enough.

  • The current study found that the number of eye surgeries had increased by 25% in 2021 compared with 2020 but 108,000 fewer eye surgeries were performed in 2021 compared to 2019.
  • However, this number was still 20% below 2019, indicating a persistent gap in surgery capacity.
  • The net result is that surgical volumes in 2021 did not return to pre-pandemic levels and the surgical wait times continued to grow, leading to vision loss that could have been prevented.

Despite funding, staff shortages remain a critical issue.

  • In March 2022, the federal government announced that $2 billion would be available to provinces to reduce the surgical backlog.
  • Despite this, the backlog continued to grow due to staff shortages including being ill due to COVID-19 or severe burnout.
  • A survey conducted by Statistics Canada in 2021 reported that 25 to 40% of health care workers were considering leaving their place of employment or changing their jobs. This is of concern as the health care system struggles to overcome the continued impact of the pandemic.

The backlog of specialized eye care has led to severe and, in some cases, irreversible outcomes for certain Canadians living with vision loss. Canadians with vision loss continue to be underserved, and many are going blind or losing vision despite the medications and treatments available.

It is crucial that we design systems and policies that correct this dangerous trend. Visit StopVisionLoss.ca and sign the petition asking the Canadian government to deliver a national eye care strategy and to address the backlog in eye care that is leading to today's preventable blindness crisis. 

Statements:

  • "While we saw some progress on vision health care in Canada in 2021, we are nowhere near pre-pandemic levels. This is adding to the crisis of preventable blindness. Even with funding commitments from federal and provincial governments, staff shortages mean eye care is majorly under-resourced in Canada," says Dr. Keith Gordon, Principal Investigator for the Report Card and Research Officer, Canadian Council of the Blind. "It is critical for Canadians to understand the importance of managing their vision health, and that they can access care and treatment in a timely manner. The time is now for passage of Bill C-284 to implement a national eye care strategy."

  • "Our health care system continues to face critical challenges brought on by the pandemic. Our latest findings on the state of vision health care in Canada show that despite some progress, we are still facing a crisis when it comes to surgical backlogs and growing wait times to access critical eye care," says Doug Earle, President and CEO, Fighting Blindness Canada. "Canadians need to take urgent steps to stop preventable blindness by receiving an eye examination and signing our petition for a national eye care strategy at StopVisionLoss.ca. Together we can stop preventable blindness in Canada."

  • "Optometrists play a critical role in examining patients and identifying preventable diseases that cause vision loss. We care about our patients, and it is concerning that they wait to receive eye care when we know the importance of treating these conditions as soon as possible," said Dr. Stephanie Kwan, OD and Optometry Partner, Specsavers in Hamilton, Ontario. "Not only do Canadians need to get their vision checked at least every two years, but they also need to ensure they are receiving a comprehensive eye exam. Specsavers has found that using Optical Coherence Tomography (OCT) is helping optometrists to identify early-stage eye disease and manage these patients effectively with accurate referrals. Our data shows that 34% of patients who were assessed with OCT had signs of vision-threatening diseases."
About "The Impact of the COVID-19 Pandemic on Vision Health in Canada 2021"

The Canadian Council of the Blind and Fighting Blindness Canada conducted a follow-up study to the Cost of Vision Loss and Blindness in Canada report. The follow-up was intended to review the current state of vision health in Canada, the current impact of the pandemic on people living with vision loss, and the overall vision health of Canadians in 2021. Quantitative data from various Canadian sources were combined with quantitative and qualitative data from a new survey of Canadians living with vision loss, conducted in July 2022. In addition, interviews were conducted with ophthalmologists, optometrists, and vision care stakeholder organizations to determine whether the quantitative data is supported by their lived experience. The 2022 Report Card on Vision Health in Canada 2021 was made possible by unconditional grants from a number of Canada's leading research-based pharmaceutical companies, corporate partners, and key members and stakeholders of the vision loss community. The Canadian Council of the Blind and Fighting Blindness Canada would like to express our appreciation to Alcon, AbbVie Allergan, AGTC, Bayer, Novartis, Roche and Specsavers for their generous support.

About the Canadian Council of the Blind

The Canadian Council of the Blind (CCB) is the Voice of the Blind™ in Canada, a membership-based charity that brings together Canadians who are living with vision loss, the blind, deaf-blind, and partially-sighted. Advocating for its members, the CCB works to promote a sense of purpose and self-esteem along with an enhanced quality of life. Based on a belief in ability, not disability, the CCB is a vibrant network of active members across Canada. Each chapter is unique to its geographic area and engages in a variety of social and recreational activities based on the interests of its local members. Visit CCBNational.net or call 1-877-304-0968 for more information.

CANADIAN COUNCIL OF THE BLIND Logo (CNW Group/Canadian Council of the Blind)

About Fighting Blindness Canada

Fighting Blindness Canada (FBC) is the largest charitable funder of vision research in Canada. FBC has invested over $40 million to research sight-saving cures and treatments for blinding eye diseases. With the support of its generous donors, FBC has funded over 200 research grants which have led to over 600 discoveries such as stem cell treatments, neuroprotective therapies, technological developments, pharmaceuticals, and gene therapies. Visit FightingBlindness.ca or call 1-800-461-3331 to learn more.

FIGHTING BLINDNESS CANADA Logo (CNW Group/Canadian Council of the Blind)

SOURCE Canadian Council of the Blind

Read More

Continue Reading

Uncategorized

Part 1: Current State of the Housing Market; Overview for mid-March 2024

Today, in the Calculated Risk Real Estate Newsletter: Part 1: Current State of the Housing Market; Overview for mid-March 2024
A brief excerpt: This 2-part overview for mid-March provides a snapshot of the current housing market.

I always like to star…

Published

on

Today, in the Calculated Risk Real Estate Newsletter: Part 1: Current State of the Housing Market; Overview for mid-March 2024

A brief excerpt:
This 2-part overview for mid-March provides a snapshot of the current housing market.

I always like to start with inventory, since inventory usually tells the tale!
...
Here is a graph of new listing from Realtor.com’s February 2024 Monthly Housing Market Trends Report showing new listings were up 11.3% year-over-year in February. This is still well below pre-pandemic levels. From Realtor.com:

However, providing a boost to overall inventory, sellers turned out in higher numbers this February as newly listed homes were 11.3% above last year’s levels. This marked the fourth month of increasing listing activity after a 17-month streak of decline.
Note the seasonality for new listings. December and January are seasonally the weakest months of the year for new listings, followed by February and November. New listings will be up year-over-year in 2024, but we will have to wait for the March and April data to see how close new listings are to normal levels.

There are always people that need to sell due to the so-called 3 D’s: Death, Divorce, and Disease. Also, in certain times, some homeowners will need to sell due to unemployment or excessive debt (neither is much of an issue right now).

And there are homeowners who want to sell for a number of reasons: upsizing (more babies), downsizing, moving for a new job, or moving to a nicer home or location (move-up buyers). It is some of the “want to sell” group that has been locked in with the golden handcuffs over the last couple of years, since it is financially difficult to move when your current mortgage rate is around 3%, and your new mortgage rate will be in the 6 1/2% to 7% range.

But time is a factor for this “want to sell” group, and eventually some of them will take the plunge. That is probably why we are seeing more new listings now.
There is much more in the article.

Read More

Continue Reading

Uncategorized

Pharma industry reputation remains steady at a ‘new normal’ after Covid, Harris Poll finds

The pharma industry is hanging on to reputation gains notched during the Covid-19 pandemic. Positive perception of the pharma industry is steady at 45%…

Published

on

The pharma industry is hanging on to reputation gains notched during the Covid-19 pandemic. Positive perception of the pharma industry is steady at 45% of US respondents in 2023, according to the latest Harris Poll data. That’s exactly the same as the previous year.

Pharma’s highest point was in February 2021 — as Covid vaccines began to roll out — with a 62% positive US perception, and helping the industry land at an average 55% positive sentiment at the end of the year in Harris’ 2021 annual assessment of industries. The pharma industry’s reputation hit its most recent low at 32% in 2019, but it had hovered around 30% for more than a decade prior.

Rob Jekielek

“Pharma has sustained a lot of the gains, now basically one and half times higher than pre-Covid,” said Harris Poll managing director Rob Jekielek. “There is a question mark around how sustained it will be, but right now it feels like a new normal.”

The Harris survey spans 11 global markets and covers 13 industries. Pharma perception is even better abroad, with an average 58% of respondents notching favorable sentiments in 2023, just a slight slip from 60% in each of the two previous years.

Pharma’s solid global reputation puts it in the middle of the pack among international industries, ranking higher than government at 37% positive, insurance at 48%, financial services at 51% and health insurance at 52%. Pharma ranks just behind automotive (62%), manufacturing (63%) and consumer products (63%), although it lags behind leading industries like tech at 75% positive in the first spot, followed by grocery at 67%.

The bright spotlight on the pharma industry during Covid vaccine and drug development boosted its reputation, but Jekielek said there’s maybe an argument to be made that pharma is continuing to develop innovative drugs outside that spotlight.

“When you look at pharma reputation during Covid, you have clear sense of a very dynamic industry working very quickly and getting therapies and products to market. If you’re looking at things happening now, you could argue that pharma still probably doesn’t get enough credit for its advances, for example, in oncology treatments,” he said.

Read More

Continue Reading

Uncategorized

Q4 Update: Delinquencies, Foreclosures and REO

Today, in the Calculated Risk Real Estate Newsletter: Q4 Update: Delinquencies, Foreclosures and REO
A brief excerpt: I’ve argued repeatedly that we would NOT see a surge in foreclosures that would significantly impact house prices (as happened followi…

Published

on

Today, in the Calculated Risk Real Estate Newsletter: Q4 Update: Delinquencies, Foreclosures and REO

A brief excerpt:
I’ve argued repeatedly that we would NOT see a surge in foreclosures that would significantly impact house prices (as happened following the housing bubble). The two key reasons are mortgage lending has been solid, and most homeowners have substantial equity in their homes..
...
And on mortgage rates, here is some data from the FHFA’s National Mortgage Database showing the distribution of interest rates on closed-end, fixed-rate 1-4 family mortgages outstanding at the end of each quarter since Q1 2013 through Q3 2023 (Q4 2023 data will be released in a two weeks).

This shows the surge in the percent of loans under 3%, and also under 4%, starting in early 2020 as mortgage rates declined sharply during the pandemic. Currently 22.6% of loans are under 3%, 59.4% are under 4%, and 78.7% are under 5%.

With substantial equity, and low mortgage rates (mostly at a fixed rates), few homeowners will have financial difficulties.
There is much more in the article. You can subscribe at https://calculatedrisk.substack.com/

Read More

Continue Reading

Trending